Acute Transverse Myelitis

Acute Transverse Myelitis

1. Acute Transverse Myelitis Ade Wijaya, MD – October 2018

2. Introduction S ince the 19th century The incidence of acute transverse myelitis is given with numbers between 1:1,000,000 for the worst cases and 8:1,000,000 per year for milder sequelae Para- or tetraplegic Rare but detrimental Greenfields JG, Norman RM. Demyelinating diseases. In: Black-wood WH , McMenemey A, Meyer, Norman RM, eds. Greenfield’s Neuropathology . Edward Arnold London ; 1971:475519. Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG . Evidenced-based guideline : clinical evaluation and treatment of transverse myelitis. Neurology . 2011;77:21282134 .

3. Diagnostic Criteria

4. Infectious Myelopathies

5. Radiology

6. Nichtweiß M, Weidauer S. Acute Transverse Myelitis: Clinical Features, Pathophysiology, and Treatment Options. InNeuroinflammation 2018 Jan 1 (pp. 141-161). Academic Press.

7. Treatment IVMP: 30 mg / kg / day (max 1 gram / day) for 5 days PLEX IVIG Others Nichtweiß M, Weidauer S. Acute Transverse Myelitis: Clinical Features, Pathophysiology, and Treatment Options. InNeuroinflammation 2018 Jan 1 (pp. 141-161). Academic Press.

8. Summary Rare but detrimental High morbidity Infectious or autoimmune IVMP PLEX / IVIG

9. THANK YOU